Norway Cancer Immunotherapy Market Size & Outlook
The cancer immunotherapy market in Norway is expected to reach a projected revenue of US$ 741.9 million by 2033. A compound annual growth rate of 9.7% is expected of Norway cancer immunotherapy market from 2025 to 2033.
Revenue, 2024 (US$M)
$324.0
Forecast, 2033 (US$M)
$741.9
CAGR, 2025 - 2033
9.7%
Report Coverage
Norway
Related Markets
Norway cancer immunotherapy market highlights
- The Norway cancer immunotherapy market generated a revenue of USD 324.0 million in 2024 and is expected to reach USD 741.9 million by 2033.
- The Norway market is expected to grow at a CAGR of 9.7% from 2025 to 2033.
- In terms of segment, monoclonal antibodies was the largest revenue generating product in 2024.
- Oncolytic Viral Therapies and Cancer Vaccines is the most lucrative product segment registering the fastest growth during the forecast period.
Cancer immunotherapy market data book summary
| Market revenue in 2024 | USD 324.0 million |
| Market revenue in 2033 | USD 741.9 million |
| Growth rate | 9.7% (CAGR from 2025 to 2033) |
| Largest segment | Monoclonal antibodies |
| Fastest growing segment | Oncolytic Viral Therapies and Cancer Vaccines |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Monoclonal Antibodies, Check Point Inhibitors, Oncolytic Viral Therapies and Cancer Vaccines |
| Key market players worldwide | Pfizer Inc, AstraZeneca PLC, Merck & Co Inc, Roche Holding AG, Bristol-Myers Squibb Co, Novartis AG ADR, Eli Lilly and Co, Johnson & Johnson, Immunocore Holdings PLC ADR |
Other key industry trends
- In terms of revenue, Norway accounted for 0.2% of the global cancer immunotherapy market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, Germany cancer immunotherapy market is projected to lead the regional market in terms of revenue in 2033.
- Spain is the fastest growing regional market in Europe and is projected to reach USD 8,506.1 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cancer Immunotherapy Market Scope
Cancer immunotherapy market segmentation & scope
Cancer Immunotherapy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Immunocore Holdings PLC ADR | View profile | 497 | 92 Park Drive, Milton Park, Abingdon, Oxfordshire, United Kingdom, OX14 4RY | https://www.immunocore.com |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Bristol-Myers Squibb Co | View profile | 34100 | Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 | https://www.bms.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Roche Holding AG | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
Norway cancer immunotherapy market size, by product, 2021-2033 (US$M)
Norway Cancer Immunotherapy Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
